Intuit Equity Method Investments increased by 38.0% to $127.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 44.3%, from $88.00M to $127.00M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 26.9% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $41.00M | $43.00M | $84.00M | $90.00M | $98.00M | $98.00M | $98.00M | $108.00M | $102.00M | $105.00M | $107.00M | $128.00M | $129.00M | $131.00M | $90.00M | $88.00M | $88.00M | $94.00M | $92.00M | $127.00M |
| QoQ Change | — | +4.9% | +95.3% | +7.1% | +8.9% | +0.0% | +0.0% | +10.2% | -5.6% | +2.9% | +1.9% | +19.6% | +0.8% | +1.6% | -31.3% | -2.2% | +0.0% | +6.8% | -2.1% | +38.0% |
| YoY Change | — | — | — | — | +139.0% | +127.9% | +16.7% | +20.0% | +4.1% | +7.1% | +9.2% | +18.5% | +26.5% | +24.8% | -15.9% | -31.3% | -31.8% | -28.2% | +2.2% | +44.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.